Douglas A Treco

This inventor holds 61 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Complement Modulation (CPC class A61K). Top assignees: Transkaryotic Therapies, Inc., Ra Pharmaceuticals, Inc., Shire Human Genetic Therapies, Inc.. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas A Treco. Retrieved from https://idiyas.com/inventor/douglas-a-treco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61 (Patent Applications = 8)

% Patents Active = 86.9

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 14 (Patent Applications = 22)

Average Co-Inventor Count = 4.1

ph-index = 17

Forward Citations = 1,051(Granted Patents)

Forward Citations (Not Self Cited) = 929(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

31 out of 40

Transkaryotic Therapies, Inc.

patents

21 out of 28

Ra Pharmaceuticals, Inc.

patents

6 out of 86

Shire Human Genetic Therapies, Inc.

patents

4. 2 out of 3,076

The General Hospital Corporation

patents

5. 1 out of 1,228

Takeda Pharmaceutical Company Limited

patents

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Complement Activity

Peptide Inhibitors

Gene Therapy

Protein Delivery

Erythropoietin

Alpha-Galactosidase

Nucleic Acid

Chimeric Polypeptide

In Vivo Production

Insulinotropin

Protein Production

Peptide Libraries

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239684 - Modulators of complement activity (2025-03-04),

2. 11965040 - Modulation of complement activity (2024-04-23),

3. 11752190 - Modulators of complement activity (2023-09-12),

4. 11723949 - Modulators of complement activity (2023-08-15),

5. 11707503 - Modulators of complement activity (2023-07-25),

6. 11535650 - Modulation of complement activity (2022-12-27),

7. 11123399 - Modulators of complement activity (2021-09-21),

8. 11116823 - Treatment of α-galactosidase a deficiency (2021-09-14),

9. 11014965 - Modulation of complement activity (2021-05-25),

10. 10954287 - Ras binding peptides and methods of use (2021-03-23),

11. 10918691 - Modulators of complement activity (2021-02-16),

12. 10835574 - Modulators of complement activity (2020-11-17),

13. 10588936 - Modulators of complement activity (2020-03-17),

14. 10508274 - Protein and peptide libraries (2019-12-17),

15. 10435438 - Modulation of complement activity (2019-10-08),

Title: The Inventive Mind of Douglas A Treco

Introduction: Douglas A Treco, a talented inventor hailing from Arlington, MA, has made significant contributions to the world of innovation with his creative ideas and groundbreaking inventions.

Latest Patents: Douglas A Treco holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patent involves a cutting-edge medical device designed to revolutionize surgical procedures.

Career Highlights: Throughout his illustrious career, Douglas A Treco has been recognized for his innovative spirit and problem-solving abilities. He has received numerous awards for his groundbreaking inventions and has been invited to speak at prestigious conferences around the world.

Collaborations: Douglas A Treco has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development of several groundbreaking technologies.

Conclusion: In conclusion, Douglas A Treco's passion for innovation and his dedication to pushing the boundaries of what is possible have established him as a prominent figure in the world of inventors. His contributions have not only improved the lives of many but have also inspired the next generation of innovators to dream big and think outside the box.

Profile summary based on public USPTO records.